Many studies have found that homozygous deletion of cyclin-dependent kinase inhibitor 2A/B (CDKN2A/B) in patients with IDH-mutant diffuse astrocytomas is a sign of poor prognosis [11,12]. The gene discussed is CDKN2A; the disease is diffuse astrocytoma.